article_metadata: Julie Leblanc Solene Hoibian Agathe Boucraut Jean-Philippe Ratone Louis Stoffaes Domitille Dano Delphine Louvel-Perrot Brice Chanez Anne-Sophie Chretien Anne Madroszyk Philippe Rochigneux
article_metadata: 10.3389/fimmu.2021.799666
article_metadata: Front Immunol
article_metadata: 2021 Dec 17;12:799666.
article_metadata: case report celiac disease digestive toxicity immune checkpoint inhibitors immune toxicity nivolumab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/34975913/
article_metadata: Celiac Disease / chemically induced Immune Checkpoint Inhibitors / adverse effects Mesothelioma / drug therapy Nivolumab / adverse effects Pleural Neoplasms / drug therapy Programmed Cell Death 1 Receptor / antagonists & inhibitors
article_metadata: Celiac Disease / chemically induced Immune Checkpoint Inhibitors / adverse effects Mesothelioma / drug therapy Nivolumab / adverse effects Pleural Neoplasms / drug therapy Programmed Cell Death 1 Receptor / antagonists & inhibitors Case Reports Research Support, Non-U.S. Gov't Aged Autoantibodies / blood Celiac Disease / diagnosis Celiac Disease / immunology Celiac Disease / therapy Diet, Gluten-Free Glucocorticoids / therapeutic use Humans Immunoglobulin A / blood Male Mesothelioma / immunology Pleural Neoplasms / immunology Programmed Cell Death 1 Receptor / immunology Protein Glutamine gamma Glutamyltransferase 2 / immunology Proton Pump Inhibitors / therapeutic use Treatment Outcome Autoantibodies Glucocorticoids Immune Checkpoint Inhibitors Immunoglobulin A PDCD1 protein, human Programmed Cell Death 1 Receptor Proton Pump Inhibitors TGM2 protein, human Nivolumab Protein Glutamine gamma Glutamyltransferase 2
article_metadata: PMC8718638
article_metadata: 34975913
article_metadata: Celiac Disease After Administration of Immune Checkpoint Inhibitors: A Case Report
article_metadata: 2021